Target colonization of Bifidobacterium bifidum in tumor-bearing mouse model and its immune activation on macrophages

Tumor

Volumn 29, Issue 8, 2009, Pages 721-726

  Jiang, Hong Rui ^a,b   Lu, Zhi Gang ^a,b   Ma, Yu Yan ^c   Liu, Ning ^a,b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Animal experimentation; Bifidobacteriales infections; Mice, nude; Stomach neoplasms

Indexed keywords

DNA; NITRIC OXIDE; RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BIFIDUM KLDS2; CANCER TISSUE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE TRANSFER; HEART; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSTIMULATION; IN VITRO STUDY; KIDNEY; LIVER; LUNG; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTE; SPLEEN; STOMACH CARCINOMA; XENOGRAFT;

EID: 77953386661     PISSN: 10007431     EISSN: None     Source Type: Journal    
DOI: 10.3781/j.issn.1000-7431.2009.08.004     Document Type: Article

References (20)

1. SCARPELLINI E, CAZZATO A, LAURITANO C, et al. Probiotics: which and when[J]. Dig Dis, 2008, 26(2): 175-182.
2. YOU HJ, OH DK, JI GE. Anticancerogenic effect of a novel chiroinositol-containing polysaccharide from Bifidobacterium bifidum BGN4[J]. FEMS Microbiol Lett, 2004, 240(2): 131-136.
3. HIRAMATSU Y, HOSONO A, TAKAHASHI K, et al. Bifidobacterium components have immunomodulatory characteristics dependent on the method of preparation[J]. Cytotechnology, 2007, 55 (2/3): 79-87.
4. LEE DK, JANG S, KIM MJ, et al. Anti-proliferative effects of Bifidobacterium adolescentes SPM0212 extract on human colon cancer cell lines[J]. BMC Cancer, 2008, 8(1): 310.
5. LI Z, FALLON J, MANDELI J, et al. A genetically enhanced anaerobic bacterium for oncopathic therapy of pancreatic cancer[J]. J Natl Cancer Inst, 2008, 100(19): 1389-1400.
6. FUJIMORI M. Genetically engineered bifidobacterium as a drug delivery system for systemic therapy of metastatic breast cancer patients[J]. Breast Cancer, 2006, 13(1): 27-31.
7. LEO C, GIACCIA AJ, DENKO NC. The hypoxic tumor microenvironment and gene expression[J]. Semin Radiat Oncol, 2008, 14(3): 207-214.
8. NIGEL P MINTON. Clostridia in cancer therapy[J]. Nat Rev Microbiol, 2003, 12(1): 237-242.
9. ZHANG L, GAO L, ZHAO L, et al. Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs[J]. Cancer Res, 2007, 67(12): 5859-5864.
10. SASAKI T, FUJIMORI M, HAMAJI Y, et al. Genetically engineered Bifidobacterium longum for tumor-targeting enzyme-prodrug therapy of autochthonous mammary tumors in rats[J]. Cancer Sci, 2006, 97(7): 649-657.
11. PERDIGÕN G, LOCASCIO M, MEDICI M, et al. Interaction of bifidobacteria with the gut and their influence in the immune function[J]. Biocell, 2003, 27(1): 1-9.
12. KIM JE, KIM JY, LEE KW, et al. Cancer chemopreventive effects of lactic acid bacteria[J]. J Microbiol Biotechnol, 2007, 17(8): 1227-1235. (Pubitemid 47377387)
13. VELAPHI SC, COOPER PA, BOLTON KD, et al. Growth and metabolism of infants born to women infected with human immunodeficiency virus and fed acidified whey-adapted starter formulas[J]. Nutrition, 2008, 24(3): 203-211.
14. LI X, FU GF, FAN YR, et al. Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth[J]. Cancer Gene Ther, 2003, 10(2): 105-111.
15. HIDAKA A, HAMAJI Y, SASAKI T, et al. Exogeneous cytosine deaminase gene expression in Bifidobacterium breve I-53-8w for tumor-targeting enzyme/ prodrug therapy[J]. Biosci Biotechnol Biochem, 2007, 71(12): 2921-2926.
16. DAVEL LE, JASNIS MA, DE LA TORRE E, et al. Arginine metabolic pathways involved in the modulation of tumor-induced angiogenesis by macrophages[J]. FEBS Lett, 2002, 532(1/2): 216-220.
17. SAYED-AHMAD MM, MOHAMAD MA. Contribution of nitric oxide and epidermal growth factor receptor in anti-metastatic potential of paclitaxel in human liver cancer cell (HebG2)[J]. J Egypt Nail Cane Inst, 2005, 17(1): 35-41.
18. TAKADA Y, SUNG B, SETII G, et al. Evidence that genetic deletion of the TNF receptor p60 or p80 inhibits Fas mediated apoptosis in macrophages[J]. Biochem Pharmacol, 2007, 74(7): 1057-1064.
19. MCKINNEY LC, GALLIGER SJ, LOWY RJ. Active and inactive influenza virus induction of tumor necrosis factor-alpha and nitric oxide in J774.1 murine macrophages: modulation by interferon-gamma and failure to induce apoptosis[J]. Virus Res, 2003, 97(2): 117-126.